FDA Tobacco Action Center

In June 2009, President Obama signed the Family Smoking Prevention and Tobacco Control Act, giving the Food and Drug Administration unprecedented authority to protect the public health by regulating tobacco products.  The ultimate success of the law will depend on an active and engaged public health community that works to support the FDA with the best evidence and input available. 

Take Action Today

Sign up to receive our FDA Tobacco Action Alerts notifying you of opportunities to strengthen FDA regulation of tobacco.


The tobacco industry has been busy challenging provisions of the Tobacco Control Act since the law passed in 2009. The Consortium has developed litigation resources to explain what is at stake in each lawsuit and track their progress through the court system.

Tobacco Control Act Cases

View Action Center Resources

Citizen Petitions

Consortium Comments


Talking Points



About the FDA Tobacco Action Center

The Family Smoking Prevention and Tobacco Control Act, gives the U.S. Food and Drug Administration unprecedented authority to regulate tobacco products. The FDA’s regulatory process requires an informed and engaged public to support bold regulation. The tobacco industry continues to commit tremendous resources to this process and the public health community must do all that it can to counter the industry’s influence.

To assist public health officials, advocates, lawyers, and researchers, the Consortium’s FDA tobacco project is working to make the FDA’s process easy to navigate. Ultimately, we are working to achieve several goals:

  • Provide strong, evidence-based information to help the FDA enact strong tobacco regulations to promote public health
  • Help the FDA defend its decisions against the tobacco industry’s legal challenges
  • Proactively engage with the FDA to shape its agenda for the benefit of public health


For questions, contact our staff attorneys:
Desmond Jenson: (651) 695-7612; Desmond.Jenson@wmitchell.edu
Joelle Lester: (651) 695-7603; Joelle.Lester@wmitchell.edu


PLEASE NOTE that although commenting on FDA regulations does not traditionally constitute lobbying, each organization must consider its own limitations based on its legal structure, funding sources and relevant law. If you have any questions regarding what activities are permitted for your organization, please contact your funder or an attorney licensed in your jurisdiction.